Dissertation > Excellent graduate degree dissertation topics show

Analysis of 52 cases with advanced non small cell lung cancer serum tumor markers

Author: ZhangAoZhe
Tutor: ZhuShiJie
School: Beijing University of Traditional Chinese Medicine
Course: Traditional Chinese Medicine
Keywords: non-small cell lung cancer CEA CA125 CA153
CLC: R734.2
Type: Master's thesis
Year: 2014
Downloads: 2
Quote: 0
Read: Download Dissertation

Abstract


ObjectiveTo assess the clinical value of serum carcinoem bryonic antigen (CEA), carbohydrate antigen125(CA125), carbohydrate antigen15-3(CA153) at base line in patients with advanced non-small cell lung cancer (NSCLC).MethodThis assay was a retrospective study of patients admitted to integrated traditional Chinese medicine (TCM) and western medicine (WM) medical department of China Japan friendship hospital from1st of January of2010to1st of May of2014. Levels of CEA, CA125, CA153in serum were studied in52patients with advanced NSCLC. Data were correlated with prognostic value, histological subtypes and Epidermal Growth Factor Receptor (EGFR). Kaplan-Meier survival and Cox regression were used to analyze the relationship of serum tumor markers and the prognosis. Log-rank test and Logistic regression were used to analyze the correlations between serum tumor markers with histological subtypes and EGFR.ResultsBasic information:52cases were all treated by integrated TCM and WM. Among which33were males and19were females (63.5%vs36.5%). Ages were form45years old to83.Adenocarcinoma were42,Squamous cell carcinoma were9,large cell caicinoma were2(80.8%vs17.3%vs1.9%).TNM stage:Ⅲb we:e9and IV were43(17.3%vs82.7%). EGFR positive were13and EGFR negative were19. Overall Survival was16.1months ranging from1month to67months. One-year survival rate was53.8%, two-year survival rate was30.8%, three-year survival rate was23.1%, five-year survival rate was1.9%.The high level of serum CEA was good prognostic factor while the high level of CA125was poor for OS, showing a significant statistical difference (P<0.05). But the level of serum CA153didn’t show a significant statistical difference (P>0.05).For the histology subtypes and EGFR. The level of serum TM did not showing a significant statistical difference (P>0.05).Conclus ionSerum CEA, CA125levels appeared to be reliable surrogate markers of prognos is and CA153was less reliable in patients with advanced NSCLC. Serum CEA, CA125, CA153levels shows no correlations with histological subtypes and EGFR status.

Related Dissertations

  1. Methylation of p16 Gene in Plasma and Tissues from Non-small Cell Lung Cancer Patients, Demethylation and the Biological Behavior of Lung Cancer Cell and Transcription of p16 Gene,R734.2
  2. Study on the Expression and Correlation of Metallothionein and Matrix Metalloproteinase-2 in Non-small Cell Lung Cancer,R734.2
  3. The Effect of RNA Interference-mediated ERCC1 Gene on the Chemo-treatment Sensitivity of NSCLC in Vitro,R734.2
  4. Non-small Cell Lung Cancer Analysis of 133 Cases of CVATS Lobectomy,R734.2
  5. Clinical Observation of Pemetrexed for Treating Advanced Non-small Cell Lung Cancer,R734.2
  6. Combined Detection of Tumor Markers in the Diagnosis and Treatment of Lung Cancer to Determine the Clinical Significance,R734.2
  7. Expression of Chemokine Receptor CCR5 in Human Non-small-cell Lung Cancer,R734.2
  8. Clinical Research on Detecing of the Combined Survivin mRNA with Cytokeratin 19(ck19) mRNA in Peripheral Blood of Non-small Cell Lung Cancer,R734.2
  9. The Molecular Biology of Rh-endostatin Plus Chemotherapy as Adjuvant Treatment for Non-small Lung Cancer,R734.2
  10. Effectiveness of Erlotinib as the Sennd-line Therapy in Patients with Advanced NSCLC,R734.2
  11. Enhancing Effect of Newcastle Disease Virus in Combination with Chemotherapy for Patients with Advanced Non-small Cell Lung Cancer,R734.2
  12. Clinical Study of Endostar Combined with Pemetrexed for Advanced Non-small Cell Lung Cancer,R734.2
  13. Association of Expression of ERCC1/RRM1 with Survival and Resistance to Platinum Inpatients with Ⅰ-ⅢA NSCLC,R734.2
  14. Analysis of Efficacy of Radiotherapy and 5-FU Slow Release Particles in Treating Non-small Cell Lung Cancer,R734.2
  15. Expression and Prognostic Significance of TS and BRCAl mRNA in Non-small Cell Lung Cancer,R734.2
  16. Restructuring Agkistrodon disintegrin Adinbitor human non-small cell lung cancer cell line A549,R285.5
  17. Non-small cell lung cancer with BMP-2 expression and significance of CD105,R734.2
  18. Expression and Pathobiological Significance of Survivin, p53 and Bcl-2 Proteins in NSCLC,R734.2
  19. Efficacy and Cost-effectiveness Analysis of the Second-line Treatment for Advanced Non-small-cell Lung Cancer,R734.2
  20. The Value of MRI and Inoperative Detection of CEA in Peritoneal Lavage in Diagnosis, Treatment and Prognosis of Gastric Carcinoma Patients,R735.2
  21. The Experimental Studies and Preliminary Clinical Application of 18F-FLT Applied for Non-small Cell Lung Cancer,R734.2

CLC: > Medicine, health > Oncology > Respiratory system tumors > Lung tumors
© 2012 www.DissertationTopic.Net  Mobile